채용
岗位职责：
- 负责原液纯化生产称量、配液、细胞培养、清洁与消毒、清场、原液储存等现场监管；
- 负责原液纯化生产管理与操作SOP的审核；
- 负责原液纯化生产质量管理文件的优化；
- 负责原液纯化生产数据与批生产记录的审核；
- 负责原液纯化生产偏差、变更、CAPA的审核，参与OOS事件调查；
- 负责原液纯化生产的放行支持；
- 负责原液纯化生产中不合格品的处理；
- 负责原液纯化生产区域环境监控管理与报警确认；
- 协助原液纯化生产涉及的物料的放行与供应商的确认；
- 协助原液纯化生产技术转移；
- 协助工厂项目注册申报工作；
- 完成上级领导交付的其他工作。
任职要求：
- 本科及以上学历，生物工程、生物技术及其他制药相关专业；
- 工作满5年以上（硕士可放宽至3年）生物制药行业质量管理相关工作2年以上；
- 英文CET-4以上。
총 조회수
0
총 지원 클릭 수
0
모의 지원자 수
0
스크랩
0
비슷한 채용공고
Manufacturing Manager 4
Emerson · Shanghai, Shanghai, China, CN
Manufacturing Process Improvement Lead (PG 31B)
Johnson & Johnson · Xian, Shaanxi, China
Manager, Manufacturing Engineering
Thermo Fisher · Guangdong, China
Production Test supervisor
Rockwell Automation · Harbin, China
Application Engineer Director – Mechanical SDA
Cadence · 2 Locations
BioNTech 소개
BioNTech
PublicBioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
1,001-5,000
직원 수
Mainz that develops immunotherapies
본사 위치
$21.7B
기업 가치
리뷰
4.0
10개 리뷰
워라밸
2.5
보상
3.8
문화
4.2
커리어
3.5
경영진
3.2
75%
친구에게 추천
장점
Innovative and cutting-edge projects
Great team and collaborative environment
Excellent benefits and flexible schedule
단점
Long working hours and high workload
Fast-paced and high-pressure environment
Management and communication issues
연봉 정보
70개 데이터
L2
L3
L4
L5
L6
Mid/L4
Intern
L2 · Data Scientist L2
0개 리포트
$53,767
총 연봉
기본급
$21,507
주식
$26,884
보너스
$5,377
$37,637
$69,897
면접 경험
1개 면접
난이도
3.0
/ 5
소요 기간
14-28주
면접 과정
1
Application Review
2
HR Screen
3
Hiring Manager Interview
4
Panel Interview
5
Final Interview
6
Offer
자주 나오는 질문
Behavioral/STAR
Technical Knowledge
Past Experience
Culture Fit
Problem Solving
뉴스 & 버즈
BioNTech’s BNT323 Achieves Strong Phase 2 Response Rates in Endometrial Cancer - Oncodaily
Oncodaily
News
·
1d ago
BioNTech And Boehringer Trial Adds Dimension To Small Cell Lung Cancer Story - simplywall.st
simplywall.st
News
·
3d ago
Biontech prepares FDA application after strong phase II results in endometrial cancer - medwatch.com
medwatch.com
News
·
6d ago
BioNTech and DualityBio report positive data for trastuzumab pamirtecan - Clinical Trials Arena
Clinical Trials Arena
News
·
6d ago